Article
Immunology
Su Jeong Lee, Bo Ruem Yoon, Hee Young Kim, Su-Jin Yoo, Seong Wook Kang, Won-Woo Lee
Summary: The study demonstrates that activated platelets induce CD16 expression on classical CD14(+)CD16(-) monocytes through soluble factors, contributing to antibody-dependent cellular phagocytosis (ADCP). CD14(+)CD16(-) monocytes treated with activated platelets preferentially differentiate into M2 macrophages, and elevated levels of the activated platelet marker sCD62P are found in plasma of rheumatoid arthritis patients.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Paola V. Ferrero, Luisina I. Onofrio, Cristina del Valle Acosta, Estefania R. Zacca, Nicolas E. Ponce, Eduardo Mussano, Laura B. Onetti, Ignacio I. Cadile, Alicia B. Costantino, Marina L. Werner, Luciana A. Mas, Teresita Alvarellos, Carolina L. Montes, Eva V. Acosta Rodriguez, Adriana Gruppi
Summary: The subsets of Tfh and Tfr cells in rheumatoid arthritis (RA) show altered dynamics after treatment and are associated with HLA class-II variants and disease activity.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Medicine, Research & Experimental
Raghunathan Jagannathan, Thodur Madapusi Balaji, Saranya Varadarajan, B. Bhuvaneswari, C. J. Venkatakrishnan, S. Lakshmi Priya, Swaminathan Rajendran, Mohammed E. Sayed, Maryam H. Mugri, Shankargouda Patil
Summary: Periodontitis has been suggested as a significant risk factor for adverse pregnancy outcomes, with elevated levels of periodontal pathogenic bacteria and proinflammatory cytokines believed to contribute to preterm delivery through placental infection and premature rupture of the amniotic membrane. The role of CD14+CD16+ monocytes in this process has not been widely researched, but potential mechanistic links between periodontitis and adverse pregnancy outcomes are being explored.
MEDICAL HYPOTHESES
(2021)
Article
Immunology
Trudy McGarry, Megan M. Hanlon, Viviana Marzaioli, Clare C. Cunningham, Vinod Krishna, Kieran Murray, Conor Hurson, Phil Gallagher, Sunil Nagpal, Douglas J. Veale, Ursula Fearon
Summary: This study reveals that monocytes in RA patients exhibit hyper-inflammatory responses and metabolic reprogramming, with evidence of this phenotype appearing before clinical manifestations of the disease.
CLINICAL & TRANSLATIONAL IMMUNOLOGY
(2021)
Review
Cardiac & Cardiovascular Systems
Yang Baoqi, Ma Dan, Zhao Xingxing, Zhu Xueqing, Wang Yajing, Xu Ke, Zhang Liyun
Summary: Rheumatoid arthritis (RA) is an autoimmune disease associated with multiple comorbidities, including cardiovascular disease, lung cancer, lymphoma, infection, and osteoporosis. Therapeutic drugs for RA can have both beneficial and harmful effects on cardiovascular events.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Shipeng Zhang, Yimeng Lei, Tao Sun, Ziyu Gao, Zhuoqi Li, Hui Shen
Summary: This study found that Metrnl is involved in the pathogenesis of rheumatoid arthritis and the increase in serum Metrnl levels is closely related to disease activity.
Article
Rheumatology
Daniel Maunder, Philip M. Brown, Ben Barron-Millar, Dennis W. Lendrem, Najib Naamane, Jamie Macdonald, Xiao N. Wang, John D. Isaacs, Amy E. Anderson, Ann W. Morgan, Rachel E. Crossland, Sarah L. Mackie, Arthur G. Pratt
Summary: This study evaluated the potential of serum EV miRs as diagnostic and therapeutic biomarkers in early RA and found a novel potential mechanism by which MTX may exert its therapeutic effect in early RA.
Review
Rheumatology
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S. Smolen, Desiree van der Heijde, Roberto Caporali, Christopher J. Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert B. M. Landewe
Summary: This study conducted a systematic literature review (SLR) to evaluate the safety of synthetic and biological disease-modifying antirheumatic drugs (DMARDs) for the management of rheumatoid arthritis (RA). The results indicated that bDMARDs were associated with an increased risk of serious infections compared to csDMARDs, while JAK inhibitors (JAKi) showed higher risk of herpes zoster infections. The risks of malignancies, major adverse cardiovascular events (MACE), and venous thromboembolism (VTE) were similar among different treatments.
ANNALS OF THE RHEUMATIC DISEASES
(2023)
Review
Medicine, General & Internal
Mengduan Pang, Zhe Sun, Hongfeng Zhang
Summary: This meta-analysis compared the risk of all-cause mortality between biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) and non-b/tsDMARDs in patients with rheumatoid arthritis (RA). The results showed that compared to non-b/tsDMARDs, antitumor necrosis factor therapy was associated with an increased risk of mortality.
Article
Cardiac & Cardiovascular Systems
Elvira D'Andrea, Rishi J. Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt, Seoyoung C. Kim
Summary: In older patients with rheumatoid arthritis, hydroxychloroquine and methotrexate showed similar risks of sudden cardiac arrest or ventricular arrhythmia (SCA/VA) and major adverse cardiovascular events (MACE). However, hydroxychloroquine initiators with a history of heart failure (HF) had higher risks of MACE, cardiovascular mortality, all-cause mortality, and myocardial infarction. An increased risk of hospitalized HF was observed among hydroxychloroquine initiators regardless of an HF history.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2022)
Article
Immunology
Zahra Mahmoudi, Negin Karamali, Seyed Askar Roghani, Shirin Assar, Mehran Pournazari, Parviz Soufivand, Farhad Salari, Alireza Rezaiemanesh
Summary: The study investigated the gene expression levels of MALAT1, H19, miR-199a-5p, and miR-1-3p in RA patients. MALAT1 and H19 may serve as potential biomarkers for distinguishing RA patients from controls.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Article
Immunology
Qinglei Yin, Dalong Song, Juan Chen, Guang Ning, Weiqing Wang, Shu Wang
Summary: CD14++CD16+ monocytes play a critical role in the pathogenesis of Graves' disease and promote the generation of potentially pathogenic Th responses in GD.
CLINICAL IMMUNOLOGY
(2022)
Review
Chemistry, Multidisciplinary
Yu Han, Shilei Huang
Summary: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints, and current treatment options are not able to cure the disease or reverse joint damage. Nanotechnology offers potential solutions through targeted drug delivery systems, anti-inflammatory properties, improved biocompatibility, and energy conversion therapies. Although still in the early stages of clinical application, nanomedicines have shown promising results in animal models and may offer a new approach in the treatment of RA.
JOURNAL OF CONTROLLED RELEASE
(2023)
Article
Medicine, General & Internal
Abelardo Caballero, Teresa Vazquez-Sanchez, Pedro Ruiz-Esteban, Myriam Leon, Juana Alonso-Titos, Veronica Lopez, Eugenia Sola, Elena Gutierrez, Mercedes Cabello, Cristina Casas-Gonzalez, Rafael Pozo-Alvarez, Juan Delgado-Burgos, Domingo Hernandez
Summary: The study revealed that CD14++CD16+ monocytes in low-immunological-risk kidney transplant recipients were significantly lower in cases of subclinical borderline lesions, potentially serving as an early indicator for rejection.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Immunology
Shuhe Ma, Kosaku Murakami, Rintaro Saito, Hiromu Ito, Koichi Murata, Kohei Nishitani, Motomu Hashimoto, Masao Tanaka, Masahi Taniguchi, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Koichiro Ohmura, Akio Morinobu, Tsuneyo Mimori
Summary: This study identified differences in the quantity and quality of CD14-positive cells in the infrapatellar fat pads and subcutaneous fat tissues of OA and RA patients. Patients treated with bDMARDs showed a higher ratio of CD14(++)CD80(+) cells/CD14(++)CD163(+) cells in the IFP, indicating localized inflammation. This suggests that adipose tissue-derived innate immune cells could be a potential target for new therapeutic strategies in inflammatory joint diseases.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Manuela Rizzi, Stelvio Tonello, Davide D'Onghia, Pier Paolo Sainaghi
Summary: Gas6 is a widely expressed protein involved in various biological processes. It serves as the main ligand for TAMs, and its activation plays a crucial role in modulating inflammatory responses and fibrotic evolution. This review focuses on Gas6/TAM axis activation in SARS-CoV-2 infection and highlights the potential therapeutic benefits of targeting Axl, a receptor member of TAMs, in COVID-19 management.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Rheumatology
Parikshit Sen, R. Naveen, Nazanin Houshmand, Siamak Moghadam Kia, Mrudula Joshi, Sreoshy Saha, Kshitij Jagtap, Vishwesh Agarwal, Arvind Nune, Elena Nikiphorou, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Nelly Ziade, Tsvetelina Velikova, Marcin Milchert, Ioannis Parodis, Abraham Edgar Gracia-Ramos, Lorenzo Cavagna, Masataka Kuwana, Johannes Knitza, Ashima Makol, Aarat Patel, John D. Pauling, Chris Wincup, Bhupen Barman, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio de la Torre, Iris J. Colunga-Pedraza, Javier Merayo-Chalico, Okwara Celestine Chibuzo, Wanruchada Katchamart, Phonpen Akawatcharangura Goo, Russka Shumnalieva, Yi-Ming Chen, Leonardo Santos Hoff, Lina El Kibbi, Hussein Halabi, Binit Vaidya, Syahrul Sazliyana Shaharir, A. T. M. Tanveer Hasan, Dzifa Dey, Carlos Enrique Toro Gutierrez, Carlo Vinicio Caballero-Uribe, James B. Lilleker, Babur Salim, Tamer Gheita, Tulika Chatterjee, Oliver Distler, Miguel A. Saavedra, Jessica Day, Hector Chinoy, Sinan Kardes, Sinan A. Kardes, Laura Andreoli, Daniele Lini, Karen Screiber, Melinda Nagy Vince, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C. Pandya, Rakesh Kumar Pilania, Aman Sharma, M. Manesh Manoj, Vikas Gupta, Chengappa G. Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arunkumar R. Pande, Kunal Chandwar, Akanksha Ghodke, Hiya Boro, Zoha Zahid Fazal, Doendue Ueskuedar Cansu, Resit Yildirim, Armen Yuri Gasparyan, Nicoletta Del Papa, Gianluca Sambataro, Atzeni Fabiola, Marcello Govoni, Simone Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Silvia Grignaschi, Alessandro Giollo, Alessia Alluno, Florenzo Ioannone, Marco Fornaro, Lisa S. Traboco, Suryo Anggoro Kusumo Wibowo, Jesus Loarce-Martos, Sergio Prieto-Gonzalez, Raquel Aranega Gonzalez, Akira Yoshida, Ran Nakashima, Shinji Sato, Naoki Kimura, Yuko Kaneko, Takahisa Gono, Stylianos Tomaras, Fabian Nikolai Proft, Marie-Therese Holzer, Margarita Aleksandrovna Gromova, Or Aharonov, Zoltan Griger, Ihsane Hmamouchi, Imane El Bouchti, Zineb Baba, Margherita Giannini, Francois Maurier, Julien Campagne, Alain Meyer, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Marie Hudson, Oceane Landon-Cardinal, Wilmer Gerardo Rojas Zuleta, Alvaro Arbelaez, Javier Cajas, Jose Antonio Pereira Silva, Joao Eurico Fonseca, Olena Zimba, Doskaliuk Bohdana, Uyi Ima-Edomwonyi, Ibukunoluwa Dedeke, Emorinken Airenakho, Nwankwo Henry Madu, Abubakar Yerima, Hakeem Olaosebikan, A. Becky, Oruma Devi Koussougbo, Elisa Palalane, Ho So, Manuel Francisco Ugarte-Gil, Lyn Chinchay, Jose Proano Bernaola, Victorio Pimentel, Hanan Mohammed Fathi, Reem Hamdy A. Mohammed, Ghita Harifi, Yurilis Fuentes-Silva, Karoll Cabriza, Jonathan Losanto, Nelly Colaman, Antonio Cachafeiro-Vilar, Generoso Guerra Bautista, Enrique Julio Giraldo Ho, Raul Gonzalez, Lilith Stange Nunez, M. Cristian Vergara, Jossiell Then Baez, Hugo Alonzo, Carlos Benito Santiago Pastelin, Rodrigo Garcia Salinas, Alejandro Quinonez Obiols, Nilmo Chavez, Andrea Bran Ordonez, Sandra Argueta, Gil Alberto Reyes Llerena, Radames Sierra-Zorita, Dina Arrieta, Eduardo Romero Hidalgo, Ricardo Saenz, M. Idania Escalante, Roberto Morales, Wendy Calapaqui, Ivonne Quezada, Gabriela Arredondo, Vikas Agarwal, Rohit Aggarwal, Latika Gupta
Summary: In this study, hesitancy in patients with autoimmune rheumatic diseases (AIRDs) towards COVID-19 vaccines was investigated. The results showed a decrease in hesitancy, but an increase in concerns over the long-term safety of the vaccine. Patients with idiopathic inflammatory myopathies (IIMs) expressed more skepticism towards vaccine science and had more concerns over long-term safety.
Article
Environmental Sciences
Gianluca Baldanzi, Beatrice Purghe, Beatrice Ragnoli, Pier Paolo Sainaghi, Roberta Rolla, Annalisa Chiocchetti, Marcello Manfredi, Mario Malerba
Summary: This study used an untargeted peptidomic approach to investigate the alterations of circulating peptides in COVID-19 patients. The results showed that peptide abundance is inversely correlated with disease severity and identified peptides related to inflammation, immune response, and coagulation processes. Additionally, changes in protein degradation patterns may be involved in the progression of the disease.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2023)
Article
Oncology
Rodolfo Sacco, Daryl Ramai, Raffaella Tortora, Giovan Giuseppe di Costanzo, Michela Emma Burlone, Mario Pirisi, Piera Federico, Bruno Daniele, Marianna Silletta, Paolo Gallo, Caterina Cocuzza, Maurizio Russello, Giuseppe Cabibbo, Gabriele Rancatore, Silvia Cesario, Gianluca Masi, Luca Marzi, Andrea Mega, Alessandro Granito, Giulia Pieri, Edoardo G. G. Giannini, Rosa Paolillo, Gennaro Gadaleta-Caldarola, Vincenzo Dadduzio, Guido Giordano, Luca Giacomelli, Simonetta Papa, Matteo Renzulli, Marcello Maida, Michele Ghidini, Mauro Borzio, Antonio Facciorusso
Summary: Hepatocellular carcinoma is the fifth most common cancer worldwide. Lenvatinib has proven to be an effective option for treating advanced diseases. Our study showed that patients with nonviral etiologies have longer survival than those with viral etiology, which is important for clinical decision-making.
Review
Neurosciences
Iris Zeqaj, Roberto Piffero, Elisa Calzaducca, Mario Pirisi, Mattia Bellan
Summary: This review aimed to evaluate the potential benefit(s) of vitamin D supplementation for CNS aging in different clinical contexts. The current literature suggests a real role for vitamin D supplementation in the prevention of cognitive decay in healthy subjects and potential benefits for patients with mild cognitive impairment. However, the data on vitamin D in Alzheimer's disease are contradictory.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
(2023)
Review
Biochemistry & Molecular Biology
Manuela Rizzi, Davide D'Onghia, Stelvio Tonello, Rosalba Minisini, Donato Colangelo, Mattia Bellan, Luigi Mario Castello, Francesco Gavelli, Gian Carlo Avanzi, Mario Pirisi, Pier Paolo Sainaghi
Summary: Clinical knowledge about SARS-CoV-2 infection mechanisms and COVID-19 pathophysiology has greatly increased. Hematologic biomarkers have been validated for early triage and monitoring of disease progression. Implementation of these markers could aid in patient stratification and guiding therapeutic intervention.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Daria Apostolo, Davide D'Onghia, Stelvio Tonello, Rosalba Minisini, Alessio Baricich, Carla Gramaglia, Filippo Patrucco, Patrizia Zeppegno, Antonio Acquaviva, Piero Emilio Balbo, Luigi Mario Castello, Giuseppe Cappellano, Annalisa Chiocchetti, Chiara Gerevini, Mara Giordano, Fatiha Laaguid, Marcello Manfredi, Davide Raineri, Cristina Rigamonti, Roberta Rolla, Valentina Romano, Marco Confalonieri, Paola Savoia, Elisa Zavattaro, Mario Pirisi, Barbara Ruaro, Pier Paolo Sainaghi, Mattia Bellan
Summary: Post-acute conditions are common after COVID-19, and the underlying mechanisms are not yet fully understood. This study suggests that Gas6 and its soluble receptors, sAxl and sMer, may be implicated in these conditions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Elena Grossini, Carlo Smirne, Sakthipriyan Venkatesan, Stelvio Tonello, Davide D'Onghia, Rosalba Minisini, Vincenzo Cantaluppi, Pier Paolo Sainaghi, Cristoforo Comi, Adele Tanzi, Benedetta Bussolati, Mario Pirisi
Summary: In this study, the role of extracellular vesicles (EVs) as pathogenic factors for the onset of HCV-related endothelial dysfunction was evaluated. The results showed that EVs from HCV patients were mainly of endothelial and lymphocyte origin and were able to reduce cell viability and mitochondrial membrane potential of vascular endothelial cells, while increasing reactive oxygen species (ROS) release. These harmful effects could be reduced by pretreatment with specific blockers.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Multidisciplinary Sciences
Maria Talmon, Marcella Percio, Joyce Afrakoma Obeng, Federico A. Ruffinatti, Daniele Sola, Pier Paolo Sainaghi, Emanuela Bellis, Stefano Cusinato, Aurora Ianniello, Luigia G. Fresu
Summary: It has been observed that patients with rheumatoid arthritis (RA) have different responses to various biologic DMARDs on the market, potentially due to the complexity of the disease. Monocytes, which play a crucial role in the development of RA, were examined in patients treated with methotrexate alone or in combination with tocilizumab, anti-TNF alpha or abatacept, as well as in healthy individuals. The study identified genes associated with inflammatory processes and immune responses, providing a foundation for personalized therapeutic choices based on gene signatures.
Article
Virology
Stelvio Tonello, Davide D'Onghia, Daria Apostolo, Erica Matino, Martina Costanzo, Giuseppe Francesco Casciaro, Alessandro Croce, Eleonora Rizzi, Erika Zecca, Anita Rebecca Pedrinelli, Veronica Vassia, Paolo Ravanini, Maria Grazia Crobu, Manuela Rizzi, Raffaella Landi, Luigi Mario Castello, Rosalba Minisini, Gian Carlo Avanzi, Mario Pirisi, Daniele Lilleri, Mattia Bellan, Donato Colangelo, Pier Paolo Sainaghi
Summary: This study aimed to evaluate osteopontin (OPN) as a potential biomarker for predicting the prognosis of COVID-19 patients. The results showed that higher plasma concentrations of OPN at hospital admission were associated with a worsening clinical condition. OPN levels might serve as a promising biomarker for early stratification of COVID-19 severity.
Article
Nutrition & Dietetics
Erica Matino, Elena Tavella, Manuela Rizzi, Gian Carlo Avanzi, Danila Azzolina, Antonio Battaglia, Paolo Becco, Mattia Bellan, Giovanni Bertinieri, Massimo Bertoletti, Giuseppe Francesco Casciaro, Luigi Mario Castello, Umberto Colageo, Donato Colangelo, Davide Comolli, Martina Costanzo, Alessandro Croce, Davide D'Onghia, Francesco Della Corte, Luigi De Mitri, Valentina Dodaro, Filippo Givone, Alessia Gravina, Luca Grillenzoni, Graziano Gusmaroli, Raffaella Landi, Anna Lingua, Roberto Manzoni, Vito Marinoni, Bianca Masturzo, Rosalba Minisini, Marina Morello, Anna Nelva, Elena Ortone, Rita Paolella, Giuseppe Patti, Anita Pedrinelli, Mario Pirisi, Lidia Ravizzi, Eleonora Rizzi, Daniele Sola, Mariolina Sola, Nadir Tonello, Stelvio Tonello, Gigliola Topazzo, Aldo Tua, Piera Valenti, Rosanna Vaschetto, Veronica Vassia, Erika Zecca, Nicoletta Zublena, Paolo Manzoni, Pier Paolo Sainaghi
Summary: Bovine lactoferrin, as a nutritional supplement, does not improve the clinical course of hospitalized patients with moderate-to-severe COVID-19. The LAC trial showed that there were no significant differences in the outcomes between lactoferrin and placebo groups, including death or ICU admission rate, and discharge or NEWS2 <= 2 within 14 days. Although lactoferrin demonstrated excellent safety and tolerability, its use in this patient population is not supported.
Article
Immunology
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, Erika Zecca, Erica Matino, Micol Cittone, Eleonora Rizzi, Giuseppe Francesco Casciaro, Davide D'Onghia, Donato Colangelo, Rosalba Minisini, Mattia Bellan, Luigi Mario Castello, Annalisa Chiocchetti, Mario Pirisi, Cristina Rigamonti, Daniele Lilleri, Federica Zavaglio, Federica Bergami, Daniele Sola, Pier Paolo Sainaghi
Summary: A significant number of immunocompromised patients did not develop detectable antibodies after receiving a full course of SARS-CoV-2 vaccination. The impact of various immunosuppressants on their risk of SARS-CoV-2 infection remains largely unknown.
FRONTIERS IN IMMUNOLOGY
(2023)
Letter
Rheumatology
Mrinalini Dey, R. Naveen, Elena Nikiphorou, Parikshit Sen, Sreoshy Saha, James B. Lilleker, Vishwesh Agarwal, Sinan Kardes, Jessica Day, Marcin Milchert, Mrudula Joshi, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Minchul Kim, Tulika Chatterjee, Ai Lyn Tan, Ashima Makol, Arvind Nune, Lorenzo Cavagna, Miguel A. Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Oliver Distler, Bhupen Barman, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C. Pandya, Rakesh Kumar Pilania, Aman Sharma, Manesh M. Manoj, Vikas Gupta, Chengappa G. Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arunkumar R. Pande, Kunal Chandwar, John D. Pauling, Chris Wincup, Dondu Uskudar Cansu, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio Garcia-De La Torre, Nicoletta Del Papa, Gianluca Sambataro, Atzeni Fabiola, Marcello Govoni, Simone Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Lisa S. Traboco, Leonardo Santos Hoff, Suryo Anggoro Kusumo Wibowo, Stylianos Tomaras, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Akira Yoshida, Ran Nakashima, Shinji Sato, Naoki Kimura, Yuko Kaneko, Jesus Loarce-Martos, Sergio Prieto-Gonzalez, Albert Gil-Vila, Raquel Aranega Gonzalez, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta